Gemphire Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing gemcabene for the treatment of dyslipidemia.
Status: Acquired by NeuroBo Pharmaceuticals in 2019
Location: United States, Michigan, Ann Arbor
Employees: 11-50
Total raised: $2.8M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | Excel Vent... | excelvm.co... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 03.09.2015 | - | $2.8M | - | finsmes.co... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 03.09.2015 | Gemphire Therapeutics Closes $2.8M Financing | Gemphire Therapeutics, a Northville, Michigan-based developer of LDL-cholesterol lowering drug gemca... | finsmes.co... |